You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,371 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
B
Not yet recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
  • lenalinomide
  • (no location specified)
2021-04-05
Apr 5, 2021
A
Active, not recruiting
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
J
Terminated
  • Central Nervous System Tumors
  • 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
  • +4 more
  • Saint Petersburg, Florida
    Johns Hopkins All Childen's Hospital
2021-03-08
Mar 8, 2021
F
Active, not recruiting
  • Multiple Myeloma
  • Melphalan, Prednisone, Lenalidomide
  • +2 more
  • Torino, TO, Italy
    Division Of Hematology, A.O.U. Città della Salute e della Scienz
2020-11-05
Nov 5, 2020
S
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2021-08-20
Aug 20, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
P
Recruiting
  • Rosai-Dorfman Disease
  • lenalidomide and dexamethasone
  • Beijing, China
    Peking Union Medical College Hospital
2021-06-11
Jun 11, 2021
N
Not yet recruiting
  • Peripheral T-cell Lymphomas (PTCL)
  • Lenalidomide and Gemcitabine (Dose level 11)
  • +3 more
  • Kaohsiung, Taiwan
  • +3 more
2021-11-01
Nov 1, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
H
Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
2021-06-16
Jun 16, 2021
M
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-07-13
Jul 13, 2021
G
Withdrawn
  • Multiple Myeloma
  • Daratumumab Only Product in Parenteral Dose Form
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-07-05
Jul 5, 2021
H
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
2021-08-25
Aug 25, 2021
N
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-23
Oct 23, 2021
H
Completed
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021
U
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-02-04
Feb 4, 2021
B
Not yet recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • (no location specified)
2021-10-21
Oct 21, 2021
B
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2021-06-27
Jun 27, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2021-09-02
Sep 2, 2021
H
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
U
Active, not recruiting
  • Richter's Syndrome
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-04-08
Apr 8, 2021
T
Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • Tokyo, Japan
    Takeda Selected Site
2021-06-03
Jun 3, 2021